Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2020

01-04-2020 | Breast Cancer | Epidemiology

Trajectory of recurrent falls in post-menopausal breast cancer survivors and in matched cancer-free controls

Authors: Kathy Pan, Roberta M. Ray, Jane A. Cauley, Aladdin H. Shadyab, Arti Hurria, Rowan T. Chlebowski

Published in: Breast Cancer Research and Treatment | Issue 3/2020

Login to get access

Abstract

Purpose

Cross-sectional studies suggest that falls are prevalent among older breast cancer survivors. However, fall risk in this population has not been comprehensively examined. Therefore, we compared fall risk in older women post-breast cancer diagnosis to fall risk before cancer diagnosis and to risk in cancer-free matched controls.

Methods

Among 2019 women in the Women’s Health Initiative with localized breast cancer diagnosed at age ≥ 60 years with fall assessment data for 3 years pre-diagnosis and 3 years post-diagnosis, recurrent fall risk post-diagnosis was compared to risk in 2019 cancer-free controls matched by age, year of WHI entry, and baseline fall frequency. Generalized estimating equations under a logistic regression model were used to compare fall recurrence in breast cancer survivors and controls. Multi-variable models were adjusted for the matching factors, race/ethnicity, body mass index, and multiple chronic conditions.

Results

In breast cancer survivors aged 70.8 years (mean) at diagnosis, over the 3-year pre-diagnosis interval, recurrent falls were reported by 18.5%. Over the 3-year post-diagnosis interval, recurrent falls were reported by 21.8% of breast cancer survivors and 20.0% of controls over the same time period (P = 0.27). Recurrent fall risk did not differ between breast cancer survivors and control women (OR 1.07, 95% CI 0.92–1.25), even after multi-variable adjustment.

Conclusions

In contrast to prior reports, older breast cancer survivors were not more likely to experience recurrent falls than age-matched counterparts. These findings underscore the need for incorporation of cancer-free control populations in survivorship studies to distinguish cancer sequelae from processes related to aging.
Literature
11.
12.
go back to reference Anderson GL, Manson J, Wallace R, Lund B, Hall D, Davis S, Shumaker S, Wang CY, Stein E, Prentice RL (2003) Implementation of the Women's Health Initiative study design. Ann Epidemiol 13(9 Suppl):S5–17CrossRef Anderson GL, Manson J, Wallace R, Lund B, Hall D, Davis S, Shumaker S, Wang CY, Stein E, Prentice RL (2003) Implementation of the Women's Health Initiative study design. Ann Epidemiol 13(9 Suppl):S5–17CrossRef
14.
16.
go back to reference Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge SB, Jacobs LA, Hurria A, Marks LB, LaMonte SJ, Warner E, Lyman GH, Ganz PA (2016) American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J Clin Oncol 34(6):611–635. https://doi.org/10.1200/jco.2015.64.3809 CrossRefPubMed Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge SB, Jacobs LA, Hurria A, Marks LB, LaMonte SJ, Warner E, Lyman GH, Ganz PA (2016) American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J Clin Oncol 34(6):611–635. https://​doi.​org/​10.​1200/​jco.​2015.​64.​3809 CrossRefPubMed
24.
go back to reference Hoskin PJ, Ashley S, Yarnold JR (1992) Weight gain after primary surgery for breast cancer–effect of tamoxifen. Breast Cancer Res Treat 22(2):129–132CrossRef Hoskin PJ, Ashley S, Yarnold JR (1992) Weight gain after primary surgery for breast cancer–effect of tamoxifen. Breast Cancer Res Treat 22(2):129–132CrossRef
25.
go back to reference Arnold BJ, Cumming CE, Lees AW, Handman MD, Cumming DC, Urion C (2001) Tamoxifen in breast cancer: symptom reporting. Breast J 7(2):97–100CrossRef Arnold BJ, Cumming CE, Lees AW, Handman MD, Cumming DC, Urion C (2001) Tamoxifen in breast cancer: symptom reporting. Breast J 7(2):97–100CrossRef
33.
go back to reference Lee R (2017) The CDC's STEADI initiative: promoting older adult health and independence through fall prevention. Am Fam Phys 96(4):220–221 Lee R (2017) The CDC's STEADI initiative: promoting older adult health and independence through fall prevention. Am Fam Phys 96(4):220–221
Metadata
Title
Trajectory of recurrent falls in post-menopausal breast cancer survivors and in matched cancer-free controls
Authors
Kathy Pan
Roberta M. Ray
Jane A. Cauley
Aladdin H. Shadyab
Arti Hurria
Rowan T. Chlebowski
Publication date
01-04-2020
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2020
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-020-05576-8

Other articles of this Issue 3/2020

Breast Cancer Research and Treatment 3/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine